Omeros Corporation (OMER) Deep Dive Video
Summary
Omeros’ Yartemlea launch is converting exclusive TA-TMA positioning into 97.2% gross-margin growth, with reimbursement catalysts supporting substantial five-year upside.
View OMER stock page · Read the OMER research report
Loading the video player…